Elsa Curtit
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 10%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
Papers in
- Oncology 23
- Cancer survivorship and care 8
- HER2/EGFR in Cancer Research 6
-
- Breast Cancer Treatment Studies 10
- Co-authors
- Xavier B. Pivot (27 shared papers)Virginie Nerich (9 shared papers)L. Chaigneau (16 shared papers)Antoine Thiery-Vuillemin (12 shared papers)Fernando Bazán (12 shared papers)Philippe Montcuquet (8 shared papers)Laura Mansi (10 shared papers)Thierry Nguyen (7 shared papers)
- Journals
- Annals of Oncology (8 papers)European Journal of Cancer (4 papers)BMC Cancer (3 papers)Frontiers in Oncology (2 papers)Breast Cancer Research (2 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Elsa Curtit
57 papers receiving 937 citations
Elsa Curtit's Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 262
- Oncology 220
- Hepatology 44
- Genetics 126
- Genetics 37
Countries citing papers authored by Elsa Curtit
This map shows the geographic impact of Elsa Curtit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Curtit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Curtit more than expected).
Fields of papers citing papers by Elsa Curtit
This network shows the impact of papers produced by Elsa Curtit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Curtit. The network helps show where Elsa Curtit may publish in the future.
Co-authors
The 25 scholars most cited alongside Elsa Curtit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 2 | 2013 | 80 | |
| 3 | 2019 | 57 | |
| 4 | 2011 | 44 | |
| 5 | 2016 | 41 | |
| 6 | 2016 | 33 | |
| 7 | 2016 | 20 | |
| 8 | 2022 | 20 | |
| 9 | 2013 | 19 | |
| 10 | 2012 | 18 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 16 | |
| 13 | 2012 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2021 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2011 | 12 | |
| 18 | 2011 | 11 | |
| 19 | 2021 | 11 | |
| 20 | 2011 | 10 |
About Elsa Curtit
Elsa Curtit is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Genetics, having authored 59 papers that have together received 956 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Cancer survivorship and care (8 papers), HER2/EGFR in Cancer Research (6 papers), BRCA gene mutations in cancer (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Glioma Diagnosis and Treatment (4 papers), Sleep and related disorders (3 papers) and Genetic Associations and Epidemiology (3 papers). The work is most often cited by research in Cancer Research (262 citations), Oncology (220 citations), Hepatology (44 citations), Genetics (126 citations) and Genetics (37 citations). Elsa Curtit has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Xavier B. Pivot, Virginie Nerich, L. Chaigneau, Antoine Thiery-Vuillemin, Fernando Bazán, Philippe Montcuquet, Laura Mansi, Thierry Nguyen, Cristian Villanueva and Samuel Limat. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, BMC Cancer, Frontiers in Oncology and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.